CN110117608A - Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening - Google Patents
Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening Download PDFInfo
- Publication number
- CN110117608A CN110117608A CN201910229594.6A CN201910229594A CN110117608A CN 110117608 A CN110117608 A CN 110117608A CN 201910229594 A CN201910229594 A CN 201910229594A CN 110117608 A CN110117608 A CN 110117608A
- Authority
- CN
- China
- Prior art keywords
- gene
- sequence
- plasmid
- ala
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 96
- 241000193830 Bacillus <bacterium> Species 0.000 title claims abstract description 45
- 238000003780 insertion Methods 0.000 title claims abstract description 23
- 230000037431 insertion Effects 0.000 title claims abstract description 23
- 238000012216 screening Methods 0.000 title claims abstract description 21
- 101100059150 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) cas10 gene Proteins 0.000 title claims abstract description 19
- 239000013612 plasmid Substances 0.000 claims abstract description 56
- 230000012010 growth Effects 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 15
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 238000012163 sequencing technique Methods 0.000 claims description 9
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 8
- 230000029087 digestion Effects 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 238000000137 annealing Methods 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 230000002452 interceptive effect Effects 0.000 claims description 5
- 230000003252 repetitive effect Effects 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 206010064571 Gene mutation Diseases 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 108091008146 restriction endonucleases Proteins 0.000 claims description 4
- 238000013461 design Methods 0.000 claims description 3
- 230000003993 interaction Effects 0.000 claims description 3
- 108091033380 Coding strand Proteins 0.000 claims description 2
- 230000006801 homologous recombination Effects 0.000 claims description 2
- 238000002744 homologous recombination Methods 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 15
- 230000008676 import Effects 0.000 abstract description 2
- 241001515965 unidentified phage Species 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 108020005004 Guide RNA Proteins 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 101150005343 INHA gene Proteins 0.000 description 5
- 101150030463 esxQ gene Proteins 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000013049 sediment Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 201000008827 tuberculosis Diseases 0.000 description 5
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 101150013110 katG gene Proteins 0.000 description 4
- 101150019655 lpqE gene Proteins 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 3
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 3
- 108010079364 N-glycylalanine Proteins 0.000 description 3
- 108010013835 arginine glutamate Proteins 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000003209 gene knockout Methods 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 108010050848 glycylleucine Proteins 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 101150070420 gyrA gene Proteins 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 2
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 2
- BYLPQJAWXJWUCJ-YDHLFZDLSA-N Asp-Tyr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O BYLPQJAWXJWUCJ-YDHLFZDLSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 description 2
- 108700035964 Mycobacterium tuberculosis HsaD Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 108010011559 alanylphenylalanine Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 1
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 1
- DWINFPQUSSHSFS-UVBJJODRSA-N Ala-Arg-Trp Chemical compound N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O DWINFPQUSSHSFS-UVBJJODRSA-N 0.000 description 1
- NXSFUECZFORGOG-CIUDSAMLSA-N Ala-Asn-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXSFUECZFORGOG-CIUDSAMLSA-N 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 1
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 1
- CRWFEKLFPVRPBV-CIUDSAMLSA-N Ala-Gln-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O CRWFEKLFPVRPBV-CIUDSAMLSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- VHVVPYOJIIQCKS-QEJZJMRPSA-N Ala-Leu-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VHVVPYOJIIQCKS-QEJZJMRPSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- RUXQNKVQSKOOBS-JURCDPSOSA-N Ala-Phe-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RUXQNKVQSKOOBS-JURCDPSOSA-N 0.000 description 1
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 1
- VRTOMXFZHGWHIJ-KZVJFYERSA-N Ala-Thr-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VRTOMXFZHGWHIJ-KZVJFYERSA-N 0.000 description 1
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 1
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 1
- FSXDWQGEWZQBPJ-HERUPUMHSA-N Ala-Trp-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FSXDWQGEWZQBPJ-HERUPUMHSA-N 0.000 description 1
- AOAKQKVICDWCLB-UWJYBYFXSA-N Ala-Tyr-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AOAKQKVICDWCLB-UWJYBYFXSA-N 0.000 description 1
- GCTANJIJJROSLH-GVARAGBVSA-N Ala-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C)N GCTANJIJJROSLH-GVARAGBVSA-N 0.000 description 1
- BHSYMWWMVRPCPA-CYDGBPFRSA-N Arg-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N BHSYMWWMVRPCPA-CYDGBPFRSA-N 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- PVSNBTCXCQIXSE-JYJNAYRXSA-N Arg-Arg-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PVSNBTCXCQIXSE-JYJNAYRXSA-N 0.000 description 1
- OVVUNXXROOFSIM-SDDRHHMPSA-N Arg-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O OVVUNXXROOFSIM-SDDRHHMPSA-N 0.000 description 1
- GHNDBBVSWOWYII-LPEHRKFASA-N Arg-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GHNDBBVSWOWYII-LPEHRKFASA-N 0.000 description 1
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 description 1
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 1
- RYRQZJVFDVWURI-SRVKXCTJSA-N Arg-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N RYRQZJVFDVWURI-SRVKXCTJSA-N 0.000 description 1
- HJDNZFIYILEIKR-OSUNSFLBSA-N Arg-Ile-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HJDNZFIYILEIKR-OSUNSFLBSA-N 0.000 description 1
- ZDBWKBCKYJGKGP-DCAQKATOSA-N Arg-Leu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O ZDBWKBCKYJGKGP-DCAQKATOSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- WMEVEPXNCMKNGH-IHRRRGAJSA-N Arg-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WMEVEPXNCMKNGH-IHRRRGAJSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- NPAVRDPEFVKELR-DCAQKATOSA-N Arg-Lys-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NPAVRDPEFVKELR-DCAQKATOSA-N 0.000 description 1
- OISWSORSLQOGFV-AVGNSLFASA-N Arg-Met-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N OISWSORSLQOGFV-AVGNSLFASA-N 0.000 description 1
- GSUFZRURORXYTM-STQMWFEESA-N Arg-Phe-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 GSUFZRURORXYTM-STQMWFEESA-N 0.000 description 1
- IGFJVXOATGZTHD-UHFFFAOYSA-N Arg-Phe-His Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc2c[nH]cn2)C(=O)O IGFJVXOATGZTHD-UHFFFAOYSA-N 0.000 description 1
- WKPXXXUSUHAXDE-SRVKXCTJSA-N Arg-Pro-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WKPXXXUSUHAXDE-SRVKXCTJSA-N 0.000 description 1
- UULLJGQFCDXVTQ-CYDGBPFRSA-N Arg-Pro-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UULLJGQFCDXVTQ-CYDGBPFRSA-N 0.000 description 1
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 1
- NVPHRWNWTKYIST-BPNCWPANSA-N Arg-Tyr-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 NVPHRWNWTKYIST-BPNCWPANSA-N 0.000 description 1
- GOVUDFOGXOONFT-VEVYYDQMSA-N Asn-Arg-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GOVUDFOGXOONFT-VEVYYDQMSA-N 0.000 description 1
- UBKOVSLDWIHYSY-ACZMJKKPSA-N Asn-Glu-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UBKOVSLDWIHYSY-ACZMJKKPSA-N 0.000 description 1
- LTZIRYMWOJHRCH-GUDRVLHUSA-N Asn-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N LTZIRYMWOJHRCH-GUDRVLHUSA-N 0.000 description 1
- ZMUQQMGITUJQTI-CIUDSAMLSA-N Asn-Leu-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O ZMUQQMGITUJQTI-CIUDSAMLSA-N 0.000 description 1
- WXVGISRWSYGEDK-KKUMJFAQSA-N Asn-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N WXVGISRWSYGEDK-KKUMJFAQSA-N 0.000 description 1
- VPPXTHJNTYDNFJ-CIUDSAMLSA-N Asp-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N VPPXTHJNTYDNFJ-CIUDSAMLSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- JGDBHIVECJGXJA-FXQIFTODSA-N Asp-Asp-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JGDBHIVECJGXJA-FXQIFTODSA-N 0.000 description 1
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 1
- HRGGPWBIMIQANI-GUBZILKMSA-N Asp-Gln-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HRGGPWBIMIQANI-GUBZILKMSA-N 0.000 description 1
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 1
- DTNUIAJCPRMNBT-WHFBIAKZSA-N Asp-Gly-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O DTNUIAJCPRMNBT-WHFBIAKZSA-N 0.000 description 1
- ZSVJVIOVABDTTL-YUMQZZPRSA-N Asp-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)N ZSVJVIOVABDTTL-YUMQZZPRSA-N 0.000 description 1
- KFAFUJMGHVVYRC-DCAQKATOSA-N Asp-Leu-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O KFAFUJMGHVVYRC-DCAQKATOSA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 1
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 1
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 1
- UXRVDHVARNBOIO-QSFUFRPTSA-N Asp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)N UXRVDHVARNBOIO-QSFUFRPTSA-N 0.000 description 1
- SFJUYBCDQBAYAJ-YDHLFZDLSA-N Asp-Val-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SFJUYBCDQBAYAJ-YDHLFZDLSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010092526 GKPV peptide Proteins 0.000 description 1
- NUMFTVCBONFQIQ-DRZSPHRISA-N Gln-Ala-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NUMFTVCBONFQIQ-DRZSPHRISA-N 0.000 description 1
- XKBASPWPBXNVLQ-WDSKDSINSA-N Gln-Gly-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XKBASPWPBXNVLQ-WDSKDSINSA-N 0.000 description 1
- PSERKXGRRADTKA-MNXVOIDGSA-N Gln-Leu-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PSERKXGRRADTKA-MNXVOIDGSA-N 0.000 description 1
- IULKWYSYZSURJK-AVGNSLFASA-N Gln-Leu-Lys Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O IULKWYSYZSURJK-AVGNSLFASA-N 0.000 description 1
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 1
- SXGMGNZEHFORAV-IUCAKERBSA-N Gln-Lys-Gly Chemical compound C(CCN)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N SXGMGNZEHFORAV-IUCAKERBSA-N 0.000 description 1
- PBYFVIQRFLNQCO-GUBZILKMSA-N Gln-Pro-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O PBYFVIQRFLNQCO-GUBZILKMSA-N 0.000 description 1
- WBBVTGIFQIZBHP-JBACZVJFSA-N Gln-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)N)N WBBVTGIFQIZBHP-JBACZVJFSA-N 0.000 description 1
- SZXSSXUNOALWCH-ACZMJKKPSA-N Glu-Ala-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O SZXSSXUNOALWCH-ACZMJKKPSA-N 0.000 description 1
- RLZBLVSJDFHDBL-KBIXCLLPSA-N Glu-Ala-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RLZBLVSJDFHDBL-KBIXCLLPSA-N 0.000 description 1
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 1
- IGKGSULCWCKNCA-SRVKXCTJSA-N Glu-Arg-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(CNC([C@H](CCCNC(N)=N)NC([C@H](CCC(O)=O)N)=O)=O)=O IGKGSULCWCKNCA-SRVKXCTJSA-N 0.000 description 1
- LTUVYLVIZHJCOQ-KKUMJFAQSA-N Glu-Arg-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LTUVYLVIZHJCOQ-KKUMJFAQSA-N 0.000 description 1
- WOSRKEJQESVHGA-CIUDSAMLSA-N Glu-Arg-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O WOSRKEJQESVHGA-CIUDSAMLSA-N 0.000 description 1
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 1
- SBYVDRJAXWSXQL-AVGNSLFASA-N Glu-Asn-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SBYVDRJAXWSXQL-AVGNSLFASA-N 0.000 description 1
- RDPOETHPAQEGDP-ACZMJKKPSA-N Glu-Asp-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RDPOETHPAQEGDP-ACZMJKKPSA-N 0.000 description 1
- RQNYYRHRKSVKAB-GUBZILKMSA-N Glu-Cys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O RQNYYRHRKSVKAB-GUBZILKMSA-N 0.000 description 1
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 1
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 1
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
- YRMZCZIRHYCNHX-RYUDHWBXSA-N Glu-Phe-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O YRMZCZIRHYCNHX-RYUDHWBXSA-N 0.000 description 1
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 1
- GQGAFTPXAPKSCF-WHFBIAKZSA-N Gly-Ala-Cys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O GQGAFTPXAPKSCF-WHFBIAKZSA-N 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 1
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 1
- NZAFOTBEULLEQB-WDSKDSINSA-N Gly-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN NZAFOTBEULLEQB-WDSKDSINSA-N 0.000 description 1
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 1
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 1
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- MHZXESQPPXOING-KBPBESRZSA-N Gly-Lys-Phe Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MHZXESQPPXOING-KBPBESRZSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- GULGDABMYTYMJZ-STQMWFEESA-N Gly-Trp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O GULGDABMYTYMJZ-STQMWFEESA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- LSQHWKPPOFDHHZ-YUMQZZPRSA-N His-Asp-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LSQHWKPPOFDHHZ-YUMQZZPRSA-N 0.000 description 1
- WEIYKCOEVBUJQC-JYJNAYRXSA-N His-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N WEIYKCOEVBUJQC-JYJNAYRXSA-N 0.000 description 1
- BZKDJRSZWLPJNI-SRVKXCTJSA-N His-His-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O BZKDJRSZWLPJNI-SRVKXCTJSA-N 0.000 description 1
- KHUFDBQXGLEIHC-BZSNNMDCSA-N His-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 KHUFDBQXGLEIHC-BZSNNMDCSA-N 0.000 description 1
- VXZZUXWAOMWWJH-QTKMDUPCSA-N His-Thr-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VXZZUXWAOMWWJH-QTKMDUPCSA-N 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- LEDRIAHEWDJRMF-CFMVVWHZSA-N Ile-Asn-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LEDRIAHEWDJRMF-CFMVVWHZSA-N 0.000 description 1
- GECLQMBTZCPAFY-PEFMBERDSA-N Ile-Gln-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GECLQMBTZCPAFY-PEFMBERDSA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- OEQKGSPBDVKYOC-ZKWXMUAHSA-N Ile-Gly-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N OEQKGSPBDVKYOC-ZKWXMUAHSA-N 0.000 description 1
- PDTMWFVVNZYWTR-NHCYSSNCSA-N Ile-Gly-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O PDTMWFVVNZYWTR-NHCYSSNCSA-N 0.000 description 1
- LWWILHPVAKKLQS-QXEWZRGKSA-N Ile-Gly-Met Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N LWWILHPVAKKLQS-QXEWZRGKSA-N 0.000 description 1
- KBAPKNDWAGVGTH-IGISWZIWSA-N Ile-Ile-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KBAPKNDWAGVGTH-IGISWZIWSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- WJBOZUVRPOIQNN-KJYZGMDISA-N Ile-Trp-His Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)C1=CN=CN1 WJBOZUVRPOIQNN-KJYZGMDISA-N 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- TWQIYNGNYNJUFM-NHCYSSNCSA-N Leu-Asn-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O TWQIYNGNYNJUFM-NHCYSSNCSA-N 0.000 description 1
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 1
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 1
- QKIBIXAQKAFZGL-GUBZILKMSA-N Leu-Cys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QKIBIXAQKAFZGL-GUBZILKMSA-N 0.000 description 1
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- HRTRLSRYZZKPCO-BJDJZHNGSA-N Leu-Ile-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HRTRLSRYZZKPCO-BJDJZHNGSA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N Leu-Phe-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 1
- SYRTUBLKWNDSDK-DKIMLUQUSA-N Leu-Phe-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYRTUBLKWNDSDK-DKIMLUQUSA-N 0.000 description 1
- RRVCZCNFXIFGRA-DCAQKATOSA-N Leu-Pro-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RRVCZCNFXIFGRA-DCAQKATOSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 1
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 1
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 1
- HQBOMRTVKVKFMN-WDSOQIARSA-N Leu-Trp-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O HQBOMRTVKVKFMN-WDSOQIARSA-N 0.000 description 1
- UCRJTSIIAYHOHE-ULQDDVLXSA-N Leu-Tyr-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UCRJTSIIAYHOHE-ULQDDVLXSA-N 0.000 description 1
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 1
- WXJKFRMKJORORD-DCAQKATOSA-N Lys-Arg-Ala Chemical compound NC(=N)NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CCCCN WXJKFRMKJORORD-DCAQKATOSA-N 0.000 description 1
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 1
- BYEBKXRNDLTGFW-CIUDSAMLSA-N Lys-Cys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O BYEBKXRNDLTGFW-CIUDSAMLSA-N 0.000 description 1
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 1
- QBHGXFQJFPWJIH-XUXIUFHCSA-N Lys-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN QBHGXFQJFPWJIH-XUXIUFHCSA-N 0.000 description 1
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 1
- ZVZRQKJOQQAFCF-ULQDDVLXSA-N Lys-Tyr-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZVZRQKJOQQAFCF-ULQDDVLXSA-N 0.000 description 1
- IEIHKHYMBIYQTH-YESZJQIVSA-N Lys-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCCN)N)C(=O)O IEIHKHYMBIYQTH-YESZJQIVSA-N 0.000 description 1
- XBAJINCXDBTJRH-WDSOQIARSA-N Lys-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N XBAJINCXDBTJRH-WDSOQIARSA-N 0.000 description 1
- BLIPQDLSCFGUFA-GUBZILKMSA-N Met-Arg-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O BLIPQDLSCFGUFA-GUBZILKMSA-N 0.000 description 1
- IHITVQKJXQQGLJ-LPEHRKFASA-N Met-Asn-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N IHITVQKJXQQGLJ-LPEHRKFASA-N 0.000 description 1
- CNAGWYQWQDMUGC-IHRRRGAJSA-N Met-Phe-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CNAGWYQWQDMUGC-IHRRRGAJSA-N 0.000 description 1
- 101100509674 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) katG3 gene Proteins 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 108010047562 NGR peptide Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- WSXKXSBOJXEZDV-DLOVCJGASA-N Phe-Ala-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@H](C)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 WSXKXSBOJXEZDV-DLOVCJGASA-N 0.000 description 1
- FPTXMUIBLMGTQH-ONGXEEELSA-N Phe-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 FPTXMUIBLMGTQH-ONGXEEELSA-N 0.000 description 1
- QMMRHASQEVCJGR-UBHSHLNASA-N Phe-Ala-Pro Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 QMMRHASQEVCJGR-UBHSHLNASA-N 0.000 description 1
- VUYCNYVLKACHPA-KKUMJFAQSA-N Phe-Asp-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N VUYCNYVLKACHPA-KKUMJFAQSA-N 0.000 description 1
- IILUKIJNFMUBNF-IHRRRGAJSA-N Phe-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O IILUKIJNFMUBNF-IHRRRGAJSA-N 0.000 description 1
- HOYQLNNGMHXZDW-KKUMJFAQSA-N Phe-Glu-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HOYQLNNGMHXZDW-KKUMJFAQSA-N 0.000 description 1
- HGNGAMWHGGANAU-WHOFXGATSA-N Phe-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HGNGAMWHGGANAU-WHOFXGATSA-N 0.000 description 1
- JQLQUPIYYJXZLJ-ZEWNOJEFSA-N Phe-Ile-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 JQLQUPIYYJXZLJ-ZEWNOJEFSA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- RTUWVJVJSMOGPL-KKUMJFAQSA-N Phe-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RTUWVJVJSMOGPL-KKUMJFAQSA-N 0.000 description 1
- FUAIIFPQELBNJF-ULQDDVLXSA-N Phe-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FUAIIFPQELBNJF-ULQDDVLXSA-N 0.000 description 1
- AAERWTUHZKLDLC-IHRRRGAJSA-N Phe-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O AAERWTUHZKLDLC-IHRRRGAJSA-N 0.000 description 1
- BPIMVBKDLSBKIJ-FCLVOEFKSA-N Phe-Thr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BPIMVBKDLSBKIJ-FCLVOEFKSA-N 0.000 description 1
- GTMSCDVFQLNEOY-BZSNNMDCSA-N Phe-Tyr-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N GTMSCDVFQLNEOY-BZSNNMDCSA-N 0.000 description 1
- VIIRRNQMMIHYHQ-XHSDSOJGSA-N Phe-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N VIIRRNQMMIHYHQ-XHSDSOJGSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- SFECXGVELZFBFJ-VEVYYDQMSA-N Pro-Asp-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SFECXGVELZFBFJ-VEVYYDQMSA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- AJBQTGZIZQXBLT-STQMWFEESA-N Pro-Phe-Gly Chemical compound C([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 AJBQTGZIZQXBLT-STQMWFEESA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- JXVXYRZQIUPYSA-NHCYSSNCSA-N Pro-Val-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JXVXYRZQIUPYSA-NHCYSSNCSA-N 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 1
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 1
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 1
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 1
- OLIJLNWFEQEFDM-SRVKXCTJSA-N Ser-Asp-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLIJLNWFEQEFDM-SRVKXCTJSA-N 0.000 description 1
- YPUSXTWURJANKF-KBIXCLLPSA-N Ser-Gln-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YPUSXTWURJANKF-KBIXCLLPSA-N 0.000 description 1
- GWMXFEMMBHOKDX-AVGNSLFASA-N Ser-Gln-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 GWMXFEMMBHOKDX-AVGNSLFASA-N 0.000 description 1
- VQBCMLMPEWPUTB-ACZMJKKPSA-N Ser-Glu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VQBCMLMPEWPUTB-ACZMJKKPSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- VZQRNAYURWAEFE-KKUMJFAQSA-N Ser-Leu-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VZQRNAYURWAEFE-KKUMJFAQSA-N 0.000 description 1
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 1
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 1
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 1
- SGZVZUCRAVSPKQ-FXQIFTODSA-N Ser-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N SGZVZUCRAVSPKQ-FXQIFTODSA-N 0.000 description 1
- RCOUFINCYASMDN-GUBZILKMSA-N Ser-Val-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O RCOUFINCYASMDN-GUBZILKMSA-N 0.000 description 1
- ANOQEBQWIAYIMV-AEJSXWLSSA-N Ser-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N ANOQEBQWIAYIMV-AEJSXWLSSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- LVHHEVGYAZGXDE-KDXUFGMBSA-N Thr-Ala-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(=O)O)N)O LVHHEVGYAZGXDE-KDXUFGMBSA-N 0.000 description 1
- XYEXCEPTALHNEV-RCWTZXSCSA-N Thr-Arg-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XYEXCEPTALHNEV-RCWTZXSCSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- UHBPFYOQQPFKQR-JHEQGTHGSA-N Thr-Gln-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UHBPFYOQQPFKQR-JHEQGTHGSA-N 0.000 description 1
- ONNSECRQFSTMCC-XKBZYTNZSA-N Thr-Glu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ONNSECRQFSTMCC-XKBZYTNZSA-N 0.000 description 1
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 1
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 1
- FDALPRWYVKJCLL-PMVVWTBXSA-N Thr-His-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O FDALPRWYVKJCLL-PMVVWTBXSA-N 0.000 description 1
- JRAUIKJSEAKTGD-TUBUOCAGSA-N Thr-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N JRAUIKJSEAKTGD-TUBUOCAGSA-N 0.000 description 1
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 1
- UGFSAPWZBROURT-IXOXFDKPSA-N Thr-Phe-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N)O UGFSAPWZBROURT-IXOXFDKPSA-N 0.000 description 1
- QJIODPFLAASXJC-JHYOHUSXSA-N Thr-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O QJIODPFLAASXJC-JHYOHUSXSA-N 0.000 description 1
- KHTIUAKJRUIEMA-HOUAVDHOSA-N Thr-Trp-Asp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 KHTIUAKJRUIEMA-HOUAVDHOSA-N 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- SGFIXFAHVWJKTD-KJEVXHAQSA-N Tyr-Arg-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SGFIXFAHVWJKTD-KJEVXHAQSA-N 0.000 description 1
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 1
- KHCSOLAHNLOXJR-BZSNNMDCSA-N Tyr-Leu-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHCSOLAHNLOXJR-BZSNNMDCSA-N 0.000 description 1
- FMXFHNSFABRVFZ-BZSNNMDCSA-N Tyr-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FMXFHNSFABRVFZ-BZSNNMDCSA-N 0.000 description 1
- NVZVJIUDICCMHZ-BZSNNMDCSA-N Tyr-Phe-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O NVZVJIUDICCMHZ-BZSNNMDCSA-N 0.000 description 1
- SZEIFUXUTBBQFQ-STQMWFEESA-N Tyr-Pro-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SZEIFUXUTBBQFQ-STQMWFEESA-N 0.000 description 1
- VYQQQIRHIFALGE-UWJYBYFXSA-N Tyr-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VYQQQIRHIFALGE-UWJYBYFXSA-N 0.000 description 1
- ZPFLBLFITJCBTP-QWRGUYRKSA-N Tyr-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O ZPFLBLFITJCBTP-QWRGUYRKSA-N 0.000 description 1
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 1
- LTTQCQRTSHJPPL-ZKWXMUAHSA-N Val-Ser-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N LTTQCQRTSHJPPL-ZKWXMUAHSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- PGBMPFKFKXYROZ-UFYCRDLUSA-N Val-Tyr-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N PGBMPFKFKXYROZ-UFYCRDLUSA-N 0.000 description 1
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 1
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 229940031567 attenuated vaccine Drugs 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000012350 deep sequencing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010033719 glycyl-histidyl-glycine Proteins 0.000 description 1
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108010084572 phenylalanyl-valine Proteins 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940125575 vaccine candidate Drugs 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Field the present invention relates to prokaryotes endogenous gene as application tool, more particularly to a kind of application of endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening, wherein, the amino acid sequence of endogenous Rv2823c coding albumen is as shown in SEQ ID No.1;The nucleotide sequence of endogenous Rv2823c gene is as shown in SEQ ID No.2.The present invention, which imports the plasmid pMV-gRNA-HDR built in tubercle bacillus, can be realized insertion, knockout or the interference of gene and the screening of mutant library.Compared with bacteriophage or swivel base submethod, the interference of growth indispensable gene is more optimizedly may be implemented in editor while this method can fast implement single or multiple gene.
Description
Technical field
Field the present invention relates to prokaryotes endogenous gene as application tool, and in particular to a kind of endogenous
Rv2823c encodes application of the albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening.
Background technique
According to the latest report of the World Health Organization (World Health Organization, WHO), by tubercle bacillus
Tuberculosis caused by (Mycobacterium tuberculosis, abbreviation Mtb) infects is one of big cause of the death in the whole world ten,
Newly-increased 1,040,000 people of tuberculosis patient in the whole world in 2016,140,000 people die of the disease.Tuberculosis death more than 95% occurs low
Income and middle income country, China are also one of pathogenetic major country of tuberculosis.Due to the unreasonable use of antibiotic
Etc. reasons, cause the appearance of multi-drug resistant and extensive drug resistance tubercle bacillus bacterial strain, this brings great challenge for the prevention and treatment of the disease.
Termination strategy lungy has been issued in the whole world, but BCG vaccine used at present becomes increasingly preventive effect lungy
It is unobvious, therefore there is an urgent need to develop novel attenuated vaccines.Parsing to tubercle bacillus gene function and its pathogenic molecular mechanism
It is most important to excavation newtype drug target spot and Vaccine candidate gene.
It is had disadvantages that however, currently used Phage Infection method knocks out tubercle bacillus virulence gene tool, such as efficiency
It is low, the period is long, some growths must the knockout of gene cannot achieve, need novel genetic manipulation tool to carry out tuberculosis point
The knockout and silencing of branch bacillus virulence gene.
Summary of the invention
It is an object of the invention to overcome the deficiencies of the prior art and provide a kind of endogenous Rv2823c coding albumen to tie
The application in gene insertion, knockout, interference and growth indispensable gene mutant library screening is carried out in core bacillus.The present invention
Analysis finds that the protein of Rv2823c coding has the function of genetic modification, which, which plays a role, only needs to provide guidance
Sequence can realize that insertion, knockout, interference and the screening in gene mutation body library of gene (only need to import gRNA
Realize the editor of gene).This method is inserted into inactivation technique, and the party much higher than traditional transposons to the editorial efficiency of gene
Method can also realize the purpose for killing bacterium, bring hope for the research and development of tuberculosis novel method for the treatment of.Endogenous nucleic acid has
Very high transformation efficiency and genetic modification efficiency.
To achieve the above object, a kind of endogenous Rv2823c coding albumen designed by the present invention carries out base in tubercle bacillus
Because of the application in insertion, knockout or interference and growth indispensable gene mutant library screening, wherein endogenous Rv2823c coding
The amino acid sequence of albumen is as shown in SEQ ID No.1;The nucleotide sequence of endogenous Rv2823c gene such as SEQ ID No.2 institute
Show.
Further, the insertion, the gene for knocking out or interfering are any one or more in the genome of tubercle bacillus
Gene.
Still further, the gene is growth indispensable gene.The tubercle bacillus is tubercle bacillus H37Rv, gene
All sequences, which disclose in NCBI, in group sees NCBI tubercle bacillus gene (https: //www.ncbi.nlm.nih.gov/
Genome/166? genome_assembly_id=159 857).
The present invention also provides a kind of suitable for gene insertion, the recombinant plasmid of knockout or interference editting function, the matter
Intragranular contains the boot sequence of more than one and tubercle bacillus target gene interactionx, x 1,2,3,4 ...;Wherein, boot sequencex
For the nucleotide sequence for arbitrarily choosing 40bp in target-gene sequence.
The recombinant plasmid library that the present invention also provides a kind of suitable for growing the screening of indispensable gene mutant library, institute
State N number of plasmid in plasmid library, the boot sequence containing 5658 with tubercle bacillus target gene interaction in all plasmidsx, x is
1,2,3,4……;Wherein, boot sequence is the nucleotide sequence of any 40bp on target gene coding strand.
Suitable for autogene insertion, the building method for the recombinant plasmid for knocking out or interfering editting function, feature exists
In: the following steps are included:
1) repetitive sequence is designed, wherein repetitive sequence repeat is tcgtcagacccaaaaccccgagaggggacgg
Aaac,
2) complex sequences repeat is aggravated at the both ends restriction enzyme site BbsI, synthesis obtains sequence repeat-BbsI-repeat;
3) repeat-BbsI-repeat is inserted into plasmid pMV-261 using the strategy of homologous recombination, that is, forms pMV-
261-crRNA (Fig. 1);
4) using the DNA sequence dna of any one gene in tubercle bacillus gene group as template, select length for 40bp's respectively
Boot sequence x;
5) single-stranded boot sequence is made to become double-strand by Gradient annealing,
6) it will be inserted into pMV261 plasmid after the BbsI digestion of double-strand boot sequence, obtain pMV261-gRNA;
It 7) is stencil design upstream and downstream homology arm according to target gene upstream and downstream gene, for the ease of screening, specificity insertion
EGFP obtains upstream homology arm -- the downstream EGFP-- homology arm sequence (HDR);Sequence HDR is by the terminator of upstream homology arm
It is removed with the promoter of EGFP, becomes an ORF;
8) pMV261-gRNA is subjected to digestion with PstI, then connected, form pMV-gRNA-HDR;
9) above-mentioned connection product is converted into stable3 infection state cell, extracts plasmid pMV-gRNA-HDR, then
Sequencing identification;Obtain recombinant plasmid pMV-gRNA-HDR.
It is answered in building insertion, the bacterial strain for knocking out or interfering editor's gene using above-mentioned recombinant plasmid pMV-gRNA-HDR
With.
It must be sieved with dispensable gene mutant library using above-mentioned recombinant plasmid library suitable for growth of bacillus tubercle
Choose application.
Beneficial effects of the present invention:
The plasmid pMV-gRNA-HDR that the present invention only needs to build, which is imported, can be realized inserting for gene in tubercle bacillus
Enter, knock out or interfere and the screening of mutant library.Compared with bacteriophage or swivel base submethod, this method can be quick
The interference of growth indispensable gene more optimizedly may be implemented in editor while realizing single or multiple gene.
Detailed description of the invention
Fig. 1 is pMV261-crRNA map;
Fig. 2 is relative position of two Repeats and BbsI in plasmid;
Fig. 3 is the fluorescence microscope detection, PCR detection and sequencing result of gene insertion;
Fig. 4 is the fluorescence microscope detection, PCR detection and sequencing result of gene delection;
Fig. 5 is the qPCR verification result of polygenes RNA interference;
Fig. 6 is mutant library the selection result.
Specific embodiment
The present invention is described in further detail combined with specific embodiments below, so as to those skilled in the art understand that.
Embodiment 1 realizes the insertion (gyrA gene) of tubercle bacillus gene using endogenous Rv2823c coding albumen
1. being suitable for the building method of the plasmid of autogene insertion, comprising the following steps:
1) according to the DNA sequence dna of gyrA gene (see NCBI tubercle bacillus gene https: //
Www.ncbi.nlm.nih.gov/gene/887105), the gene order of 40bp: (GTCTGGTCTGCGCCGTTGGCG is selected
TCCACGGCATTATCGTCGC), as spacer.
2) according to existing document report, the repeat sequence (gtcgtcagacccaaaaccccgagag of 36bp is selected
Gggacggaaac it), and among two repeats is inserted into a BbsI restriction enzyme site (repeat-BbsI-repeat), it will
The sequence is sent to Nanjing Genscript Biotechnology Co., Ltd.'s synthesis.
Relative position of two Repeats and BbsI in plasmid as shown in Fig. 2,
3) to carry out digestion actual conditions to plasmid with BbsI as follows:
Reaction system
37 DEG C of effect 2h.
4) single-stranded gRNA is made to become double-strand by Gradient annealing, actual conditions are as follows:
Reaction system
37 DEG C of 30min, 95 DEG C of 5min, then by the gradient cooling of 5 DEG C/min to 25 DEG C.Finally by double-strand oligo
200 times of dilution for connecting reaction.
Double-strand gRNA is such as
5) gRNA is inserted into pMV261 plasmid, actual conditions are as follows:
Linked system
16 DEG C of incubation 1-2h.
6) in order to be inserted into EGFP, therefore upstream and downstream homology arm (upstream homology arm -- the downstream EGFP-- of 400bp is devised
Homology arm).Meanwhile removing the promoter of the terminator of upstream homology arm and EGFP, become an ORF.
7) above-mentioned connection product is converted into stable3 infection state cell, extracts plasmid (pMV-gRNA-gyrA-
EGFP), then sequencing identification.
2. utilizing the screening of plasmid pMV-gRNA-gyrA-EGFP gene insertion tubercle bacillus strain
1) 0.5 μ g is taken to identify the tubercle bacillus H37Ra of correct recombinant plasmid pMV-gRNA-gyrA-EGFP and 200 μ l
Competent cell ice bath 10min.
2) competent cell containing recombinant plasmid is transferred in 0.2 centimetre of sterile electric revolving cup.
3) electroporation GenePulser Xcell (BIO-RAD) parameter is set as 2.5kV, 25 μ F, 1000 Ω.
4) when hearing a sound of " drop ", illustrate that electricity changes into function, be immediately transferred to the competent cell after electric shock newly
Sterile EP tube.
5) the 7H9 culture medium containing 10%OADC, 0.02%Tween 80 and 0.5% glycerol of addition 1ml preheating is to the electricity
In revolving cup.
6) for 24 hours by the cell incubation in step 5.
7) the cell 3000rpm in step 6 is centrifuged 10min, inhales and abandons supernatant.
8) bacterial sediment is resuspended with 100 μ l fresh cultures, and is coated with the 7H10 plate for containing kanamycins (50 μ g/ μ l)
It is grown to single colonie.
9) Olympus IX73 fluorescence microscope is observed.
As shown in Fig. 2, having converted the bacterium colony of the plasmid containing gRNA under fluorescence microscope it can be seen that apparent green is glimmering
Light, and control plasmid then can't see green fluorescence, illustrate that EGFP is successfully plugged into bacterial genomes.
3. being sequenced and analyzing
1) the positive bacterium solution of identification is taken into 10 μ l, and boils 5min, to crack bacterium.
2) 1 μ l sample is taken to carry out PCR amplification as template.It is specific as follows:
Reaction system
Reaction condition
Primer information
3) PCR product of 5 μ l is taken to carry out agarose gel electrophoresis.Fluorescent positive clone detects 1.8kb's as the result is shown
Band, and control group is then without corresponding band (Fig. 3 B).
4) taking the identification of 40 μ l previous steps, correctly positive PCR product send Wuhan Qing Ke biotechnology company to be sequenced, to slotting
Enter gene to be verified.Egfp gene is inserted in the end of gyrA gene as the result is shown, illustrates that egfp gene is successfully plugged into
In tubercle bacillus gene group (Fig. 3 C).
Embodiment 2 realizes that tubercle bacillus gene knocks out (by taking esxQ as an example) using endogenous Rv2823c coding albumen
1. being suitable for the building method for the recombinant plasmid that autogene knocks out, comprising the following steps:
1) according to the DNA sequence dna of esxQ gene (see NCBI tubercle bacillus gene https: //
Www.ncbi.nlm.nih.gov/gene/888508), the gene order (CACCAGCCGGTCCGAAACGTCG of 40bp is selected
GGTGATTGGTTGACGGCT), as spacer.
2) according to existing document report, the repeat sequence (gtcgtcagacccaaaaccccgagag of 36bp is selected
Gggacggaaac it), and among two repeats is inserted into a BbsI restriction enzyme site (repeat-BbsI-repeat), it will
The sequence is sent to Nanjing Genscript Biotechnology Co., Ltd.'s synthesis.
3) digestion is carried out to plasmid with BbsI, specific as follows:
Reaction system
37 DEG C of effect 2h.
4) single-stranded gRNA is made to become double-strand by Gradient annealing, actual conditions are as follows:
Reaction system
37 DEG C of 30min, 95 DEG C of 5min, then by the gradient cooling of 5 DEG C/min to 25 DEG C.Finally by double-strand oligo
200 times of dilution for connecting reaction.
5) gRNA is inserted into pMV261 plasmid, actual conditions are as follows:
Linked system
16 DEG C of incubation 1-2h.
6) for screening-gene knock-out bacterial strain, we replace target gene with BFP, therefore devise the upstream and downstream of 400bp
Homology arm (upstream homology arm -- the downstream BFP-- homology arm).
7) above-mentioned connection product is converted into stable3 infection state cell, and carries out bacterium solution PCR identification.Specifically such as
Under:
Reaction system
Primer is from plasmid backbone, for detecting HDR, to avoid the amplification gene from genome.Primer sequence is such as
Under:
Reaction condition
8) it extracts PCR and identifies correct recombinant plasmid (pMV-gRNA-esxQ-BFP), further sequencing detection.
2. utilizing the screening of plasmid pMV-gRNA-esxQ-BFP gene knockout tubercle bacillus strain
Detailed in Example 1
3. being sequenced and analyzing
1) the positive bacterium solution of identification is taken into 10 μ l, and boils 5min, to crack bacterium.
2) 1 μ l sample is taken to carry out PCR amplification as template.It is specific as follows:
Reaction system
Reaction condition
Primer information
3) 50 μ l PCR products is taken to carry out agarose gel electrophoresis.Fluorescent positive clone detects 1.6kb's as the result is shown
Band, and control group then detects the band (Fig. 4 B) of 1.4kb.
4) it send Wuhan Qing Ke biotechnology company to be sequenced after purification positive PCR product, is verified to gene is knocked out.
Bfp gene replacement esxQ gene (Fig. 4 C) as the result is shown.
4.DNA library construction, sequencing and analysis
1) picking wild strain, mutant strain and plasmid control bacterial strain single bacterium fall in 7H9 culture medium and cultivate to OD600nm
It is 1.0.
2) 6000rpm is centrifuged 15min and collects bacterial sediment.
3) bacterial sediment is resuspended in the TE buffer of 1ml.
4) it adds the SDS (1%) of 1ml and is incubated for 10min.
5) 100 μ l Proteinase Ks, 55 DEG C of incubation 3h are added.
6) RNase (Roche, Mannheim, Germany) of 100 μ l DNase-free, 37 DEG C of overnight incubations are added.
7) it adds 1mL phenol/chloroform/isoamyl alcohol (25:24:1) and cracks bacterium, 13000rpm is centrifuged 15min.
8) step 7) is repeated three times.
9) supernatant is transferred in a new centrifuge tube.
10) the 3M sodium acetate (pH=5.2) of 0.1 times of volume is added.
11) 100% ethyl alcohol for adding proper volume becomes 80% ethyl alcohol.
12) 13000rpm centrifugation 15min, 4 DEG C.
13) 80% ethanol washing DNA is precipitated three times, each 30s.
14) DNA is resuspended without DNA enzymatic water, and measures its concentration.
15) library is constructed using Nextera Illumina kit.Fragmentation processing, 55 DEG C of works are carried out to DNA with Tn5
Use 30min.It is specific as follows:
16) DNA of fragmentation is attached in different connectors, joint information is as follows:
17) KAPA HiFi archaeal dna polymerase is expanded, specific as follows:
Reaction system
Reaction condition
18) Ampure XP beads is only praised using Nanjing promise to purify library.
19) HiSeq 2000paired-ended (2x 151bp) technology carries out deep sequencing.
20) sequencing result is shown, compared with wild strain, mutant strain has lacked esxQ gene, illustrates successful knockout esxQ
Gene (Fig. 4 D and E).
Embodiment 3 realizes that polygenic interference (is with katG, inhA and lpqE gene using Rv2823c coding albumen
Example)
1. being suitable for the building method of the recombinant plasmid of autogene interference, comprising the following steps:
1) according to katG, inhA and lpqE gene (see NCBI tubercle bacillus gene
https://www.ncbi.nlm.nih.gov/gene/885638;
https://www.ncbi.nlm.nih.gov/gene/886523;
Https: //www.ncbi.nlm.nih.gov/gene/887254) non-coding sequence finds motif (5 '-
GAAAC-3 '), the gene order of motif downstream 40bp, as guide sequence (spacer).
gatG:TGTTGTCCCATTTCGTCGGGGTGTTCGTCCATACGACCTC inhA:
GCGATCGACGAGTCGGTGATGATTCCGCTAACCAGAATCC lpqE:
GTCGGGTGATTGGTTGACGGCTACCAGCACCAGATCCACC
2) repetitive sequence (repeats) that a upper 36bp is added at the both ends spacer, then by repeats-
Spacer-repeats-spacer-repeats-spacer-repeats sends to Wuhan Qing Ke biotech company and is synthesized
(lpqE-katG-ihnA-gRNA)。
3) digestion is carried out to pMV-261 plasmid with BbsI, specific as follows:
Reaction system
37 DEG C of effect 2h.
4) single-stranded lpqE-katG-ihnA-gRNA is made to become double-strand by Gradient annealing, actual conditions are as follows:
Reaction system
37 DEG C of 30min, 95 DEG C of 5min, then by the gradient cooling of 5 DEG C/min to 25 DEG C.Finally by double-strand oligo
200 times of dilution for connecting reaction.5) lpqE-katG-ihnA-gRNA is inserted into pMV261 plasmid, actual conditions are as follows:
Linked system
16 DEG C of incubation 1-2h.
6) for screening-gene knock-out bacterial strain, we replace target gene with BFP, therefore devise the upstream and downstream of 400bp
Homology arm (upstream homology arm -- the downstream BFP-- homology arm).
7) above-mentioned connection product is converted into stable3 infection state cell, and carries out bacterium solution PCR identification.Specifically such as
Under:
Reaction system
Reaction condition
8) it extracts PCR and identifies correct recombinant plasmid (pMV-gRNA-katG), further sequencing detection.
Verifying of the 3.qPCR to related gene low expression
1) it chooses positive, plasmid control and wild-type bacterium single bacterium falls in 7H9 culture medium (10ml) and cultivates to OD600nm
It is 1.0.
2) 3000rpm is centrifuged 10min and collects bacterial sediment and freeze in -80 DEG C.
3) bacterial sediment is transferred in mortar, and adds appropriate liquid nitrogen, grind 2min to destroy cell wall.
4) bacterial chip is transferred in the EP pipe of no RNA enzyme and adds 1mlTrizol.
5) it adds in appropriate Lysing Matrix B (MP USA) to the pipe.
6) 6000rpm vortex 1min is further crushed bacterium.
7) 200 μ l chloroforms of addition into bacterial lysate and are vortexed 30 seconds.
8) 12000rpm takes the aqueous phase solution of 400 μ l into new EP pipe after being centrifuged 15min.
9) isopropanol and the mixing of 400 μ l are added, incubation at room temperature 10min precipitates RNA.
10) 13000rpm is centrifuged 30min.
11) 80% ethanol washing RNA precipitate of fresh configuration three times, 30 seconds every time.
12) 13000rpm, which is centrifuged to inhale as far as possible after 5min, abandons residual ethanol.
13) RNA is resuspended in 20 μ l nuclease-free waters after being air-dried 10min.
14) genomic DNA remaining with the removal of TURBO DNA-free kit.It is specific as follows:
Reaction system
It mixes gently, is incubated for 30min.Add the DNase Inactivation Reagent room temperature effect of 0.1 times of volume
RNA is transferred in new EP pipe after 5min, 10000rpm centrifugation 1.5min.
16) after Nanodrop measures RNA concentration, adjustment RNA concentration is 100ngRNA
17) RNA is inverted to cDNA.It is specific as follows:
Reaction system
18) PerfeCTaSYBR green Supermix applied Biosystems 7300real time PCR is used
System carries out relative quantification detection to katG, inhA and lpqE gene.It is specific as follows:
Reaction system
Reaction condition
Primer information
PMV-lpqE-katG-inhA-gRNA plasmid turns Gization C group GlpqE, katG and inhA expression quantity point as the result is shown
Do not decline, and there is significant difference (Fig. 5) compared with the control group.
Embodiment 4 realizes the screening in gene mutation body library using Rv2823c coding albumen
The synthesis of 1.gRNA plasmid library
1) according to the sequence information of tubercle bacillus H37Rv genome (https: //www.ncbi.nlm.nih.gov/
Genome/166? genome_assembly_id=159 857), design is directed to the gRNA of 5658 tubercle bacillus genes and send
It is synthesized toward company.Designed gRNA is inserted into pMV261-crRNA plasmid, to form plasmid library
(method of pMV261-crRNA plasmid construction is shown in embodiment 1).
2. the screening of gene mutation body strain library
Detailed in Example 1
Target gene varies less after plasmid library expands in Escherichia coli as the result is shown, and after tubercle bacillus amplification
Variation is then very big, illustrates that library can interfere with the growth indispensable gene (Fig. 6 A and B) of tubercle bacillus.Simultaneously it has also been found that with big
Enterobacteria is compared, and library can influence the expression (Fig. 6 C and D) of some genes of tubercle bacillus.These differential genes are analyzed
It was found that 208 belong to growth of bacillus tubercle auxiliary gene and 385 growth of bacillus tubercle indispensable genes (Fig. 6 E).At 208
80% gene has been confirmed in growth auxiliary gene, illustrates that this method can be used for the screening of mutant library.Preceding
15% belongs to oxin-antitoxin family, 35% belongs to the gene packet of pressure GAP-associated protein GAP, 10% in 20 growth related genes
It is to assume albumen containing zone of ignorance, 15% and 25% is Unknown Function albumen (Fig. 6 F).208 growths of comparative analysis assist base
Probiotics genome finds that these gene pairs probiotics have certain side effect, the thermodynamic chart of preceding 31 genes in cause and 43
It shows and the similitude of 43 kinds of probiotics (Fig. 6 G) to the greatest extent.
Other unspecified parts are the prior art.Although above-described embodiment is made that in detail the present invention
Description, but it is only a part of the embodiment of the present invention, rather than whole embodiments, people can also exist according to the present embodiment
Without other embodiments are obtained under the premise of creativeness, these embodiments belong to the scope of the present invention.
Sequence table
<110>Hua Zhong Agriculture University
<120>endogenous Rv2823c coding albumen is in tubercle bacillus gene insertion, knockout, interference and mutant library screening
Using
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 809
<212> PRT
<213>tubercle bacillus H37Rv (Mycobacterium tuberculosis H37Rv)
<400> 1
Met Asn Pro Gln Leu Ile Glu Ala Ile Ile Gly Cys Leu Leu His Asp
1 5 10 15
Ile Gly Lys Pro Val Gln Arg Ala Ala Leu Gly Tyr Pro Gly Arg His
20 25 30
Ser Ala Ile Gly Arg Ala Phe Met Lys Lys Val Trp Leu Arg Asp Ser
35 40 45
Arg Asn Pro Ser Gln Phe Thr Asp Glu Val Asp Glu Ala Asp Ile Gly
50 55 60
Val Ser Asp Arg Arg Ile Leu Asp Ala Ile Ser Tyr His His Ser Ser
65 70 75 80
Ala Leu Arg Thr Ala Ala Glu Asn Gly Arg Leu Ala Ala Asp Ala Pro
85 90 95
Ala Tyr Ile Ala Tyr Asn Ile Ala Ala Gly Thr Asp Arg Arg Lys Ala
100 105 110
Asp Ser Asp Asp Gly His Gly Ala Ser Thr Trp Asp Pro Asp Thr Pro
115 120 125
Leu Tyr Ser Met Phe Asn Arg Phe Gly Ser Gly Thr Ala Asn Leu Ala
130 135 140
Phe Ala Pro Glu Met Leu Asp Asp Arg Lys Pro Ile Asn Ile Pro Ser
145 150 155 160
Pro Arg Arg Ile Glu Phe Asp Lys Asp Arg Tyr Ala Ala Ile Val Asn
165 170 175
Lys Leu Lys Ala Ile Leu Val Asp Leu Glu Arg Ser Asp Thr Tyr Leu
180 185 190
Ala Ser Leu Leu Asn Val Leu Glu Ala Thr Leu Ser Phe Val Pro Ser
195 200 205
Ser Thr Asp Ala Ser Glu Val Val Asp Val Ser Leu Phe Asp His Leu
210 215 220
Lys Leu Thr Gly Ala Leu Gly Ala Cys Ile Trp His Tyr Leu Gln Ala
225 230 235 240
Thr Gly Gln Ser Asp Phe Lys Ser Ala Leu Phe Asp Lys Gln Asp Thr
245 250 255
Phe Tyr Asn Glu Lys Ala Phe Leu Leu Thr Thr Phe Asp Val Ser Gly
260 265 270
Ile Gln Asp Phe Ile Tyr Thr Ile His Ser Ser Gly Ala Ala Lys Met
275 280 285
Leu Arg Ala Arg Ser Phe Tyr Leu Glu Met Leu Thr Glu His Leu Ile
290 295 300
Asp Glu Leu Leu Ala Arg Val Gly Leu Ser Arg Ala Asn Leu Asn Tyr
305 310 315 320
Ser Gly Gly Gly His Ala Tyr Leu Leu Leu Pro Asn Thr Glu Ser Ala
325 330 335
Arg Lys Ser Val Glu Gln Phe Glu Arg Glu Ala Asn Asp Trp Leu Leu
340 345 350
Glu Asn Phe Ala Thr Arg Leu Phe Ile Ala Thr Gly Ser Val Pro Leu
355 360 365
Ala Ala Asn Asp Leu Met Arg Arg Pro Asn Glu Ser Ala Ser Gln Ala
370 375 380
Ser Asn Arg Ala Leu Arg Tyr Ser Gly Leu Tyr Arg Glu Leu Ser Glu
385 390 395 400
Gln Leu Ser Ala Lys Lys Leu Ala Arg Tyr Ser Ala Asp Gln Leu Arg
405 410 415
Glu Leu Asn Ser Arg Asp His Asp Gly Gln Lys Gly Asp Arg Glu Cys
420 425 430
Ser Val Cys His Thr Val Asn Arg Thr Val Ser Ala Asp Asp Glu Pro
435 440 445
Lys Cys Ser Leu Cys Gln Ala Leu Thr Ala Ala Ser Ser Gln Ile Gln
450 455 460
Ser Glu Ser Arg Arg Phe Leu Leu Ile Ser Asp Gly Ala Thr Lys Gly
465 470 475 480
Leu Pro Leu Pro Phe Gly Ala Thr Leu Thr Phe Cys Ser Arg Ala Asp
485 490 495
Ala Asp Lys Ala Leu Gln Gln Pro Gln Thr Arg Arg Arg Tyr Ala Lys
500 505 510
Asn Lys Phe Phe Ala Gly Glu Cys Leu Gly Thr Gly Leu Trp Val Gly
515 520 525
Asp Tyr Val Ala Gln Met Glu Phe Gly Asp Tyr Val Lys Arg Ala Ser
530 535 540
Gly Ile Ala Arg Leu Gly Val Leu Arg Leu Asp Val Asp Asn Leu Gly
545 550 555 560
Gln Ala Phe Thr His Gly Phe Met Glu Gln Gly Asn Gly Lys Phe Asn
565 570 575
Thr Ile Ser Arg Thr Ala Ala Phe Ser Arg Met Leu Ser Leu Phe Phe
580 585 590
Arg Gln His Ile Asn Tyr Val Leu Ala Arg Pro Lys Leu Arg Pro Ile
595 600 605
Thr Gly Asp Asp Pro Ala Arg Pro Arg Glu Ala Thr Ile Ile Tyr Ser
610 615 620
Gly Gly Asp Asp Val Phe Val Val Gly Ala Trp Asp Asp Val Ile Glu
625 630 635 640
Phe Gly Ile Glu Leu Arg Glu Arg Phe His Glu Phe Thr Gln Gly Lys
645 650 655
Leu Thr Val Ser Ala Gly Ile Gly Met Phe Pro Asp Lys Tyr Pro Ile
660 665 670
Ser Val Met Ala Arg Glu Val Gly Asp Leu Glu Asp Ala Ala Lys Ser
675 680 685
Leu Pro Gly Lys Asn Gly Val Ala Leu Phe Asp Arg Glu Phe Thr Phe
690 695 700
Gly Trp Asp Glu Leu Leu Ser Lys Val Ile Glu Glu Lys Tyr Arg His
705 710 715 720
Ile Ala Asp Tyr Phe Ser Gly Asn Glu Glu Arg Gly Met Ala Phe Ile
725 730 735
Tyr Lys Leu Leu Glu Leu Leu Ala Glu Arg Asp Asp Arg Ile Thr Lys
740 745 750
Ala Arg Trp Val Tyr Phe Leu Thr Arg Met Arg Asn Pro Thr Gly Asp
755 760 765
Thr Ala Pro Phe Gln Gln Phe Ala Asn Arg Leu His Gln Trp Phe Gln
770 775 780
Asp Pro Thr Asp Ala Lys Gln Leu Lys Thr Ala Leu His Leu Tyr Ile
785 790 795 800
Tyr Arg Thr Arg Lys Glu Glu Ser Glu
805
<210> 2
<211> 2430
<212> DNA
<213>tubercle bacillus H37Rv (Mycobacterium tuberculosis H37Rv)
<400> 2
atgaacccgc aactcatcga ggccataatc ggctgcctct tgcacgacat tggcaaaccg 60
gtccagcgcg cggcgctcgg ctacccgggc aggcacagtg cgattggccg cgcttttatg 120
aagaaggtgt ggttgcgcga cagccgcaat ccgtcgcagt tcaccgacga ggtggatgag 180
gctgacattg gggtctccga ccgccgcatt ctcgacgcga tcagctatca ccacagttct 240
gcgctgcgta cggcggccga gaatggccgc cttgccgccg atgcgccggc ctacatcgcc 300
tacaatatcg cggccggaac cgaccgccgc aaggccgact ccgacgacgg ccatggtgcg 360
agcacttggg atccggacac gcccctgtat tcgatgttca accgattcgg ctccggcaca 420
gcgaatctgg catttgcccc ggagatgctc gacgaccgca agccgatcaa tataccgtcg 480
ccacgccgga tcgaattcga caaggaccgc tacgccgcca tcgtcaacaa acttaaagcc 540
attctggtcg acctcgaacg ttccgacacc tacctcgcca gcctcctcaa cgtcctcgag 600
gcgacgctgt cgttcgtgcc gtcctcgacc gacgcgtccg aggtcgtcga cgtctcactc 660
ttcgaccacc tgaagctgac gggtgcgctc ggcgcctgca tctggcacta cctacaagcc 720
accggacaaa gcgacttcaa gtcagcgctg ttcgacaagc aggacacctt ctacaacgaa 780
aaagccttcc tgctcacaac tttcgacgtc tcaggcatcc aggacttcat ctacacgatc 840
cattcctcgg gtgccgcgaa gatgctgcgt gcccgcagct tctacctgga gatgctgacc 900
gagcatctca tcgacgagct acttgcgcgg gtgggtctca gccgcgcgaa tctcaactac 960
tccggcggcg ggcacgcgta cctgctgctg cccaacacgg agtccgcgcg gaaatccgtc 1020
gaacagttcg agcgtgaggc caacgactgg ctgctggaaa acttcgcaac ccggctcttc 1080
atcgccacgg gcagcgtacc gcttgccgcg aacgacctga tgcgtcggcc gaacgagagt 1140
gcgagccagg caagtaaccg cgccctccgc tacagcgggc tctaccgtga gttgagcgag 1200
caactttccg cgaagaagct cgcccgatac agcgctgacc aactgcggga actcaactcg 1260
cgcgatcacg acggtcagaa aggtgaccgg gaatgcagcg tgtgccacac ggtcaaccgc 1320
acggtcagcg ccgacgacga gccaaagtgc agcctgtgcc aagcgctgac cgctgcgtct 1380
tcgcagattc aatccgagtc tcgccgcttc ctactcatct ctgacggcgc caccaaaggt 1440
ctgcccctgc cgttcggcgc cacactcacg ttctgtagcc gagccgacgc cgataaggca 1500
ctccagcaac cccaaacccg aaggcggtac gcgaagaaca agttcttcgc cggcgagtgt 1560
ttgggcaccg ggctctgggt gggcgactac gtcgcacaga tggagttcgg tgactacgtg 1620
aagcgtgcga gcggaatcgc gcgcctcggg gttctgcgcc ttgacgtcga taacctgggc 1680
caggcattca cgcacggctt catggagcaa ggcaacggca agttcaacac gattagccgc 1740
acggccgcgt tctcccggat gctgtcgttg ttcttccggc agcacatcaa ctacgtgttg 1800
gcacgcccga aactgcgccc gatcaccggc gatgacccgg cgcggccccg cgaggccacg 1860
atcatctact ccggtggcga tgacgtcttc gtcgtgggcg cgtgggacga cgtcatcgag 1920
ttcgggatcg agcttcggga gcggttccac gaattcaccc agggcaaact caccgtgtcg 1980
gctggcatcg gcatgttccc cgacaagtac cccatctccg tgatggcccg cgaagtcgga 2040
gatctcgaag acgcggcgaa gtcgctgccc ggcaagaacg gggttgcact cttcgatcgc 2100
gagttcacct tcggctggga tgagctgctc agcaaggtga tcgaggagaa gtaccggcac 2160
atcgccgact atttcagtgg caacgaagaa cgcggcatgg ccttcatcta caagctgctc 2220
gaactactcg ccgaacgcga cgatcgaatc acaaaggcca gatgggtgta cttcctcacg 2280
cgcatgcgta accccaccgg tgacacagcg ccttttcagc agtttgctaa ccggctacac 2340
caatggttcc aagatccgac agacgccaag caactcaaga ccgcgctgca cctctacatc 2400
tatcgcactc gcaaggagga gtccgaatga 2430
Claims (8)
1. a kind of endogenous Rv2823c coding albumen carries out gene insertion, knockout or interference in tubercle bacillus and growth is required
Application in gene mutation body library screening, wherein the amino acid sequence such as SEQ ID No.1 of endogenous Rv2823c coding albumen
It is shown;The nucleotide sequence of endogenous Rv2823c gene is as shown in SEQ ID No.2.
2. application according to claim 1, it is characterised in that: the insertion, the gene for knocking out or interfering are tubercle bacillus
Genome in any one or more genes.
3. application according to claim 1, it is characterised in that: still further, the gene is growth indispensable gene.
4. a kind of suitable for the insertion of gene described in claim 1, the recombinant plasmid of knockout or interference editting function, feature exists
In: the boot sequence x, x 1,2,3,4 ... containing more than one and tubercle bacillus target gene interaction in the plasmid;Wherein,
Boot sequence x is the nucleotide sequence that 40bp is arbitrarily chosen in target-gene sequence.
5. a kind of recombinant plasmid library suitable for growth indispensable gene mutant library screening described in claim 1, feature
It is: N number of plasmid in the plasmid library, the boot sequence containing 5658 with tubercle bacillus target gene interaction in all plasmids
X, x 1,2,3,4 ...;Wherein, boot sequence is the nucleotide sequence of any 40bp on target gene coding strand.
6. being suitable for the building of autogene insertion, the recombinant plasmid for knocking out or interfering editting function described in a kind of claim 4
Method, it is characterised in that: the following steps are included:
1) repetitive sequence is designed, wherein repetitive sequence repeat is tcgtcagacccaaaaccccgagaggggacggaaac,
2) complex sequences repeat is aggravated at the both ends restriction enzyme site BbsI, synthesis obtains sequence repeat-BbsI-repeat;
3) repeat-BbsI-repeat is inserted into plasmid pMV-261 using the strategy of homologous recombination, that is, forms pMV-261-
crRNA;
4) using the DNA sequence dna of any one gene in tubercle bacillus gene group as template, select length for the guidance of 40bp respectively
Sequence x;
5) single-stranded boot sequence is made to become double-strand by Gradient annealing,
6) it will be inserted into pMV261 plasmid after the BbsI digestion of double-strand boot sequence, obtain pMV261-gRNA;
It 7) is stencil design upstream and downstream homology arm according to target gene upstream and downstream gene, for the ease of screening, specificity is inserted into EGFP,
Obtain upstream homology arm -- the downstream EGFP-- homology arm sequence;Sequence HDR is opened the terminator of upstream homology arm and EGFP's
Mover removes, and becomes an ORF;
8) pMV261-gRNA is subjected to digestion with PstI, then connected, form pMV-gRNA-HDR;
9) above-mentioned connection product is converted into stable3 infection state cell, extracts plasmid pMV-gRNA-HDR, then sequencing mirror
It is fixed;Obtain recombinant plasmid pMV-gRNA-HDR.
7. a kind of in building insertion, knockout or interfere editor's base using the recombinant plasmid pMV-gRNA-HDR of claim 4 or 6
It is applied in the bacterial strain of cause.
8. a kind of, using recombinant plasmid library is stated described in claim 5, growth of bacillus tubercle is required and dispensable gene being suitable for
It is applied in mutant library screening.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910229594.6A CN110117608A (en) | 2019-03-25 | 2019-03-25 | Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910229594.6A CN110117608A (en) | 2019-03-25 | 2019-03-25 | Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110117608A true CN110117608A (en) | 2019-08-13 |
Family
ID=67520613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910229594.6A Pending CN110117608A (en) | 2019-03-25 | 2019-03-25 | Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110117608A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113136372A (en) * | 2021-05-28 | 2021-07-20 | 广西大学 | Construction method of recombinant phage |
CN113981547A (en) * | 2021-11-12 | 2022-01-28 | 博雅缉因(北京)生物科技有限公司 | Method for efficiently constructing sgRNAs plasmid library |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103698512A (en) * | 2013-11-25 | 2014-04-02 | 广东体必康生物科技有限公司 | Application of mycobacterium tuberculosis proteins in preparation of products used for diagnosis of latent tuberculosis infection |
WO2017081097A1 (en) * | 2015-11-09 | 2017-05-18 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | Crispr-cas sgrna library |
-
2019
- 2019-03-25 CN CN201910229594.6A patent/CN110117608A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103698512A (en) * | 2013-11-25 | 2014-04-02 | 广东体必康生物科技有限公司 | Application of mycobacterium tuberculosis proteins in preparation of products used for diagnosis of latent tuberculosis infection |
WO2017081097A1 (en) * | 2015-11-09 | 2017-05-18 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | Crispr-cas sgrna library |
Non-Patent Citations (4)
Title |
---|
GUAN J等: "Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in Staphylococcus aureus", 《MSPHERE.》 * |
RAHMAN K等: "Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening", 《GENOMICS PROTEOMICS BIOINFORMATICS》 * |
WEI W等: "Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features", 《FASEB J.》 * |
郝梦圆等: "CRISPRs基因编辑技术研究进展", 《生物技术通报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113136372A (en) * | 2021-05-28 | 2021-07-20 | 广西大学 | Construction method of recombinant phage |
CN113981547A (en) * | 2021-11-12 | 2022-01-28 | 博雅缉因(北京)生物科技有限公司 | Method for efficiently constructing sgRNAs plasmid library |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114410625B (en) | RNA-guided DNA cleavage by Cas9-crRNA complex | |
WO2017090761A1 (en) | Method for converting monocot plant genome sequence in which nucleic acid base in targeted dna sequence is specifically converted, and molecular complex used therein | |
CN111607594B (en) | CRISPR-Cas9 editing technology-based cell line for knocking out pig IRF8 gene and construction method thereof | |
US5300431A (en) | Positive selection vector for the bacteriophage P1 cloning system | |
CN109022449B (en) | Cucumber CsMLO1 gene and construction method and application of silent expression vector thereof | |
CN108277231B (en) | CRISPR system for corynebacterium genome editing | |
CN104109687A (en) | Construction and application of Zymomonas mobilis CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-association proteins)9 system | |
JPH10304876A (en) | Improved recombinant dna molecule | |
CN106755037A (en) | Streptomyces virginiae IBL14 type I-B-sv14 CAS gene editing system | |
CN108220288B (en) | Polynucleotide, transformant and application thereof | |
CN110117608A (en) | Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening | |
CN109234221B (en) | Potato X virus attenuated vaccine and preparation method and application thereof | |
EP2383337B1 (en) | Novel promoter for use in transformation of algae | |
CN113136372B (en) | Construction method of recombinant phage | |
CN110591994B (en) | Sodium hydroxide stimulation-based vibrio harveyi homologous recombination gene knockout method | |
CN116121288B (en) | Vector for cloning pseudomonas putida large fragment DNA and application thereof | |
CN110591993A (en) | Vibrio harveyi homologous recombination gene knockout method based on hydrochloric acid stimulation | |
JP2024509048A (en) | CRISPR-related transposon system and its usage | |
JP2024509047A (en) | CRISPR-related transposon system and its usage | |
CN110066819B (en) | Anti-phage and anti-virus system based on DNA (deoxyribonucleic acid) phosphorothioation modification | |
CN114457071A (en) | RNA type toxin commonly used in archaea and bacteria and related biological material thereof | |
CN109385439A (en) | The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis | |
CN114480464B (en) | Double plasmid construction method of vibrio parahaemolyticus CRISPRi | |
CN112175981A (en) | Vibrio harveyi site-directed gene knockout method based on stimulation of absolute ethyl alcohol or sodium dodecyl sulfate | |
CN117683755B (en) | C-to-G base editing system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190813 |
|
RJ01 | Rejection of invention patent application after publication |